A thorough, documented plan for monitoring and risk mitigation is essential for any ongoing consideration of TRT in service. A member already receiving TRT may face non-deployable status or limitations on certain assignments depending on the treating clinician’s guidance and medical evaluation. In many cases, active TRT present at the time of enlistment can result in a medical waiver process or could lead to non-qualification for certain occupations or assignments. Recruiters and medical evaluators assess whether TRT would impact basic training, precision in performance, or deployability. The DoD emphasizes medical readiness, safety, and the ability to perform duties without impairment. We process personal information and consumer health data to provide you with our products and services and maintain essential website functionality. For more information about the relationship between Hone and the medical practices, click here. Gradual absorption causes more stable testosterone levels in the blood. TRT can cause fluctuations in testosterone levels, which can affect energy levels, libido, mood, and the presence of symptoms such as breast tenderness. However, doctors do not usually recommend TRT as the first course of action for low testosterone levels, even for males who show such symptoms. It can cause benefits and side effects and may not be safe for people who have a high risk of certain health conditions. Deployment eligibility can be affected by TRT, with clinicians evaluating the stability of treatment and its impact on performance. These steps help ensure that TRT management remains aligned with medical safety and military readiness standards while protecting career progression and mission capability. Service members considering or currently on TRT should take deliberate steps to align treatment with military requirements. The overall objective is to determine whether TRT can be safely maintained without compromising mission readiness or the health of the service member. The process emphasizes transparent communication between the service member, medical providers, and the unit leadership. "We are now seeing a lot of young patients with low T, which is due to environmental factors," McDevitt says. Testosterone levels peak in the earlier phases of life as a teen and young adult (6). The researchers don’t factor in pre-existing conditions or peoples’ lifestyles, which can skew the results, she notes. Many countries, including the United States, don’t allow people to legally purchase T supplements for TRT without a prescription. There’s also a form of TRT that involves rubbing testosterone on your gums twice daily. Your best option will depend on your medical needs as well as your lifestyle. If your T levels are only slightly low for your age, you probably don’t need TRT. But there aren’t many studies on the long-term effects of TRT (for example, over decades). If you don’t have these health concerns, TRT is generally safe. This is why healthcare providers do extensive evaluations and tests before approving the use of TRT. Within 1 to 2 years of TRT, your doctor will measure your bone density if you had osteoporosis when treatment began. If your levels are OK you'll stay on your current dose. They are inexpensive compared to other treatments. A nasal gel is now available that eliminates the risk of exposure to others. Otherwise they could get testosterone in their system. With vigilant monitoring of serum estrogen levels, TRT has been shown to promote weight loss. Only a few case-reports describe a relationship between male breast cancer and TRT.38,39 Exogenous testosterone is known to cause an imbalance in the hypothalamic-pituitary axis. Case reports regarding testosterone supplementation leading to changes in hair patterns have been documented; however no randomized, placebo-controlled trials exist. While polycythemia may be an adverse side-effect, this is a potential benefit in patients with chronic renal failure and anemia. In patients with end-stage renal disease (ESRD) on dialysis, fluid shifts are less of a concern in patients on TRT since the fluid retention can be handled with dialysis. It has also been shown that TRT may improve hepatic function in patients with end-stage liver disease.
